Free Trial

ProQR Therapeutics (PRQR) Earnings Date, Estimates & Call Transcripts

ProQR Therapeutics logo
$1.58 -0.14 (-8.14%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$1.60 +0.02 (+1.58%)
As of 06:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ProQR Therapeutics Earnings Summary

ProQR Therapeutics released Q4 2025 earnings on March 12, 2026, reporting an EPS of -$0.09, which missed analysts' consensus estimates of -$0.08 by $0.01. Quarterly revenue was reported to be $5.53 million, below analysts' expectations of $6.12 million. With a trailing EPS of -$0.46, ProQR Therapeutics' earnings are expected to decrease next year, from ($0.53) to ($0.65) per share.

Upcoming
Earnings Date
May. 14Before Market OpensEstimated
Consensus EPS
(Mar. 12)
-$0.08
Actual EPS
(Mar. 12)
-$0.09 Missed By -$0.01
Actual Revenue
(Mar. 12)
$5.53M

Q4 2025 Earnings Resources

PRQR Upcoming Earnings

ProQR Therapeutics' Q1 2026 earnings is estimated for Thursday, May 14, 2026, based on past reporting schedules, with a conference call scheduled at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ProQR Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ProQR Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PRQR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRQR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ProQR Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.13-$0.13-$0.13
Q2 20261-$0.13-$0.13-$0.13
Q3 20261-$0.09-$0.09-$0.09
Q4 20261-$0.09-$0.09-$0.09

ProQR Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2026
(Estimated)
-------
3/12/2026Q4 2025-$0.08-$0.09 -$0.01-$0.09$6.12M$5.53M
11/6/2025Q3 2025-$0.10-$0.12 -$0.02-$0.1174$7.05M$3.38M
8/7/2025Q2 2025-$0.08-$0.14 -$0.06-$0.14$5.01M$4.33M
5/8/2025Q1 2025-$0.09-$0.1082 -$0.0182-$0.11$4.90M$4.89M
11/7/2024--$0.12-$0.11+$0.01-$0.11$4.75M$4.22M
8/8/2024--$0.12-$0.03+$0.09-$0.03$3.32M$6.79M
5/9/2024Q1 2024-$0.12-$0.10+$0.02-$0.10$3.31M$4.83M

Data powered by Fiscal.ai.

ProQR Therapeutics Earnings - Frequently Asked Questions

ProQR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 14th, 2026 based off last year's report dates. Learn more on PRQR's earnings history.

In the previous quarter, ProQR Therapeutics (NASDAQ:PRQR) missed the analysts' consensus estimate of ($0.08) by $0.01 with a reported earnings per share (EPS) of ($0.09). Learn more on analysts' earnings estimate vs. PRQR's actual earnings.

ProQR Therapeutics (NASDAQ:PRQR) has a recorded annual revenue of $17.99 million.

ProQR Therapeutics (NASDAQ:PRQR) has a recorded net income of -$47.73 million. PRQR has generated -$0.46 earnings per share over the last four quarters.

ProQR Therapeutics' earnings are expected to decrease from ($0.53) per share to ($0.65) per share in the next year.


This page (NASDAQ:PRQR) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners